Cardiovascular Disease Risk in Women With Endometriosis

Recruiting Early Phase 1 Interventional Study
Endometriosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 45
Sex
Female
Trial phase
Early Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
40 (estimated)
Sponsor
Yale University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

To test the hypothesis that estrogen suppression impairs endothelial dysfunction in endometriosis.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Young women between the ages of 18 and 45 years (Controls); * Young women between the ages of 18 and 45 years with endometriosis. Exclusion Criteria: * Subjects who smoke * Subjects who have diabetes, * Subjects with sleep apnea or BP\>140/90 will be excluded. * Women with e…
Contacts

Nina Stachenfeld, PhD

203-562-9901

nina.stachenfeld@yale.edu

CONTACT